Gilead Sciences’ remdesivir has courted high hopes as a potential treatment for COVID-19—so high, in fact, that the company previously had to shut down emergency access to the drug. Now, Gilead’s manufacturing of remdesivir is operating at light speed, and free doses of the drug are getting ready to ship.